Thus, the observed decrease in NAMPT expression in ALS/PDC brains suggests that abnormal mitochondrial bioenergetics may represent a key pathogenic mechanism underlying ALS/PDC. The gene discussed is PDC; the disease is amyotrophic lateral sclerosis.